Position in CYTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,028,697
+$3,309,318 QoQ
Shares Held
129,460
+10.5% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#117
of 477 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. CYTK ranks #20 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
515,343 | $29,956,888 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
845,118 | $29,908,726 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
419,773 | $25,337,498 | |
| 4 | CLDX |
Celldex Therapeutics, Inc.
|
647,836 | $24,105,977 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
95,335 | $23,335,147 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
1,051,465 | $22,985,024 | |
| 7 | MRNA |
Moderna, Inc.
|
274,820 | $19,245,644 | |
| 8 | MLYS |
Mineralys Therapeutics, Inc.
|
649,027 | $17,510,748 |
All Filings in CYTK
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,028,697 | 129,460 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,719,379 | 117,120 | Shares | Sole | 2026-08-11 | |
| 2025-12-31 | $3,260,237 | 51,310 | Shares | Sole | 2026-08-11 | |
| 2025-09-30 | $2,883,201 | 52,460 | Shares | Sole | 2026-08-11 | |
| 2025-06-30 | $1,995,285 | 60,390 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,674,900 | 116,320 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,760,307 | 58,680 | Shares | Sole | 2026-08-11 | |
| 2024-09-30 | $2,569,776 | 48,670 | Shares | Sole | 2026-08-11 | |
| 2024-06-30 | $3,868,885 | 71,408 | Shares | Sole | 2026-08-11 | |
| 2024-03-31 | $3,061,703 | 43,670 | Shares | Sole | 2026-08-11 | |
| 2023-12-31 | $3,658,531 | 43,820 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $455,157 | 15,450 | Shares | Sole | 2023-11-13 | |
| 2022-12-31 | $1,793,532 | 39,143 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,896,478 | 39,143 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,305,449 | 33,226 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,209,871 | 32,868 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $224,253 | 4,920 | Shares | Sole | 2022-02-14 | |
| 2020-12-31 | $762,293 | 36,684 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||